Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph clinical trials

Explore recruiting pulmonary arterial hypertension pah pulmonary hypertension associated with interstitial lung disease ild ph clinical trials.

Recruiting pulmonary arterial hypertension pah pulmonary hypertension associated with interstitial lung disease ild ph studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE 2A, OPEN-LABEL SINGLE ARM MULTICENTER EXPLORATORY STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF ORAL DOSES OF ROC-101 IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) AND PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE (ILD-PH)

Spain, Italy, Poland, France, Latvia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph trials by city

Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Toronto Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Vancouver Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Montreal Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Calgary Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Edmonton Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Ottawa Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Winnipeg Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Quebec City Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Hamilton Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Kitchener Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in London Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Halifax Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in New York Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Los Angeles Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Chicago Pulmonary Arterial Hypertension Pah Pulmonary Hypertension Associated With Interstitial Lung Disease Ild Ph in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease